- Home
- Automated
- List of product information
- ELLA TABLET 30MG [SIN13979P]
ELLA TABLET 30MG [SIN13979P]
Active ingredients: ELLA TABLET 30MG
Last updated 26 October 2025
On this page
Product Info
ELLA TABLET 30MG
[SIN13979P]
Product information
Active Ingredient and Strength | ULIPRISTAL ACETATE - 30 MG |
Dosage Form | TABLET |
Manufacturer and Country | CENEXI - FRANCE |
Registration Number | SIN13979P |
Licence Holder | HYPHENS PHARMA PTE. LTD. |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | G03AD02 |
4.1 Therapeutic indications
Emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.
4.2 Posology and method of administration
Posology
The treatment consists of one tablet to be taken orally as soon as possible, but no later than 120 hours (5 days) after unprotected intercourse or contraceptive failure.
The tablet can be taken with or without food.
If vomiting occurs within 3 hours of Ella intake, another tablet should be taken.
Ella can be taken at any moment during the menstrual cycle.
Pregnancy should be excluded before Ella is administered.
Special populations
Renal or hepatic impairment:
In the absence of specific studies, no specific dose recommendations for Ella can be made.
Severe hepatic impairment:
In the absence of specific studies, Ella is not recommended.
Children and adolescents:
A limited number of women under 18 years were included in clinical trials of Ella.
Method of administration
Oral use.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information.
Pregnancy.